Literature DB >> 8401780

Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia.

D S Knopman1.   

Abstract

The group of progressive dementing illnesses that lack distinctive histologic features includes at least four variants: a cortical type, a thalamostriate type, a motor neuronopathy type and a leukogliotic type. While the clinical presentation of some cases is that of anterograde amnesia, progressive aphasia and dysexecutive syndrome are the most common initial symptom complexes. A large number of reported cases are familial, although no abnormal gene has been identified. Pathologically, these illnesses are defined by cortical, hippocampal, striatal, medial thalamic, nigral and motor nuclei cell dropout and astrogliosis. In some cases, white matter gliosis is striking. Identification of specific histological or molecular markers of at least some of these conditions will greatly advance our understanding of these specific conditions as well as dementing illnesses in general.

Entities:  

Mesh:

Year:  1993        PMID: 8401780     DOI: 10.1159/000107354

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  10 in total

Review 1.  The birth and early evolution of the frontotemporal dementia (FTD) concept.

Authors:  Arne Brun; Lars Gustafson
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 2.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

3.  Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.

Authors:  David J Irwin; Nigel J Cairns; Murray Grossman; Corey T McMillan; Edward B Lee; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-12-31       Impact factor: 17.088

4.  Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications.

Authors:  M Sjögren; S Folkesson; K Blennow; E Tarkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

5.  Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.

Authors:  D M Bowen; A W Procter; D M A Mann; J S Snowden; M M Esiri; D Neary; P T Francis
Journal:  Psychopharmacology (Berl)       Date:  2007-11-18       Impact factor: 4.530

6.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Authors:  Nigel J Cairns; Manuela Neumann; Eileen H Bigio; Ida E Holm; Dirk Troost; Kimmo J Hatanpaa; Chan Foong; Charles L White; Julie A Schneider; Hans A Kretzschmar; Deborah Carter; Lisa Taylor-Reinwald; Katherine Paulsmeyer; Jeffrey Strider; Michael Gitcho; Alison M Goate; John C Morris; Manjari Mishra; Linda K Kwong; Anna Stieber; Yan Xu; Mark S Forman; John Q Trojanowski; Virginia M-Y Lee; Ian R A Mackenzie
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

7.  Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Clinical and neuropathological features of a neurodegenerative disorder in the central nervous system with progressive head drooping (Kubisagari).

Authors:  N Nakao; K Sahashi; M Takahashi; T Ibi; Y Hashizume
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 9.  Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.

Authors:  Arenn F Carlos; Keith A Josephs
Journal:  J Neurol       Date:  2022-03-23       Impact factor: 6.682

Review 10.  Neuropathology of frontotemporal lobar degeneration: a review.

Authors:  Valéria Santoro Bahia; Leonel Tadao Takada; Vincent Deramecourt
Journal:  Dement Neuropsychol       Date:  2013 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.